Drugs / hNSC-01
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT07451613 Comparator | Apr 2026 → Jun 2028 expected | Huntington disease | Leslie Thompson | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hNSC-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07451613 ↗ |
| Modality | Cell therapy | “neural stem cell therapy” NCT07451613 ↗ |